Express Diagnostics Int’l today announced that it has received Health Canada Class III approval to market and sell its DrugCheck® NxStep Onsite Drug Screen Cup in Canada. The urinalysis screening device received Class III approval for 24 different drugs and detection levels, including cotinine (nicotine), EDDP, K2/spice (synthetic marijuana), ketamine, and alcohol.
(PRWeb June 19, 2013)
Read the full story at http://www.prweb.com/releases/2013/6/prweb10843108.htm